The second wave in kinase cancer drugs

被引：56

作者：

Garber, K

机构：

来源：

NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 02期

关键词：

D O I：

10.1038/nbt0206-127

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Cancer drugs targeting signaling pathways have been hampered by problems of efficacy and tumor resistance. Will the next generation of kinase inhibitors fare better than the first? Ken Garber investigates.

引用

页码：127 / 130

页数：4

共 9 条

[1] Multi-kinase inhibitors create buzz at ASCO [J].

Branca, MA .

NATURE BIOTECHNOLOGY, 2005, 23 (06) :639-639

[2] Strategies to overcome resistance to targeted protein kinase inhibitors [J].

Daub, H ;

Specht, K ;

Ullrich, A .

NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (12) :1001-1010

[3] Tyrosine kinases as targets for cancer therapy [J].

Krause, DS ;

Van Etten, RA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :172-187

[4] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[5] The protein kinase complement of the human genome [J].

Manning, G ;

Whyte, DB ;

Martinez, R ;

Hunter, T ;

Sudarsanam, S .

SCIENCE, 2002, 298 (5600) :1912-+

[6] Strategies for the design of potent and selective kinase inhibitors [J].

McInnes, C ;

Fischer, PM .

CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) :1845-1863

[7] Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR [J].

Neshat, MS ;

Mellinghoff, IK ;

Tran, C ;

Stiles, B ;

Thomas, G ;

Petersen, R ;

Frost, P ;

Gibbons, JJ ;

Wu, H ;

Sawyers, CL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10314-10319

[8] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy [J].

Paez, JG ;

Jänne, PA ;

Lee, JC ;

Tracy, S ;

Greulich, H ;

Gabriel, S ;

Herman, P ;

Kaye, FJ ;

Lindeman, N ;

Boggon, TJ ;

Naoki, K ;

Sasaki, H ;

Fujii, Y ;

Eck, MJ ;

Sellers, WR ;

Johnson, BE ;

Meyerson, M .

SCIENCE, 2004, 304 (5676) :1497-1500

[9] An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice [J].

Podsypanina, K ;

Lee, RT ;

Politis, C ;

Hennessy, I ;

Crane, A ;

Puc, J ;

Neshat, M ;

Wang, H ;

Yang, L ;

Gibbons, J ;

Frost, P ;

Dreisbach, V ;

Blenis, J ;

Gaciong, Z ;

Fisher, P ;

Sawyers, C ;

Hedrick-Ellenson, L ;

Parsons, R .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10320-10325

← 1 →